Testosterone 3 CMO Antibody (3T16): sc-53455

Testosterone 3 CMO Antibody (3T16) is a mouse monoclonal IgG1 kappa light chain antibody that detects the Testosterone 3 CMO protein by enzyme-linked immunosorbent assay (ELISA). Anti-Testosterone 3 CMO antibody (3T16) is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates. Testosterone 3 CMO, also known as Testosterone-3-carboxy-methyl-oxyme, is a steroid hormone belonging to the androgen group, primarily secreted by the testis, with smaller amounts produced in the ovaries, adrenal cortices, and placenta, typically derived from cholesterol. This hormone plays a crucial role in the development of male external genitalia during fetal growth and is essential for stimulating protein synthesis, which contributes to the greater muscular development observed in males. Additionally, Testosterone 3 CMO is responsible for the emergence of male secondary sex characteristics, such as facial hair and deeper voice, and is vital for overall health and well-being in both males and females. Post-translational modifications of Testosterone 3 CMO, such as phosphorylation and glycosylation, can influence activity and stability, impacting physiological functions and interactions with other proteins. These modifications are important for regulating hormone bioavailability and ability to bind to androgen receptors, thereby affecting various biological processes, including metabolism and reproductive functions.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Testosterone 3 CMO Antibody (3T16) References:

1. Plasma dihydrotestosterone in normal adult males and its relation to testosterone.  |  Pirke, KM. and Doerr, P. 1975. Acta Endocrinol (Copenh). 79: 357-65. PMID: 1173494
2. Influence of different combinations of antibodies and penicillinase-labeled testosterone derivatives on sensitivity and specificity of immunoassays.  |  Rassaie, MJ., et al. 1992. Steroids. 57: 112-8. PMID: 1621265
3. The development of a radioimmunoassay system for testosterone (T) and dihydrotestosterone (DHT). Part 1. The preparation of the T-derivatives and T-protein conjugates.  |  Neacşu, E., et al. 1990. Endocrinologie. 28: 25-31. PMID: 2080417
4. Antigen heterologous enzyme linked immunosorbent assay for the measurement of DHEA in serum.  |  Shrivastav, TG., et al. 2011. J Immunoassay Immunochem. 32: 326-41. PMID: 21728824
5. Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.  |  Bahrke, MS., et al. 1990. Sports Med. 10: 303-37. PMID: 2263798
6. Steroid analogs inhibit hormone binding by an extract from Nippostrongylus brasiliensis (Nematoda).  |  Majundar, TK., et al. 1987. Comp Biochem Physiol B. 88: 81-4. PMID: 3677617
7. Active immunization of prepubertal boars against testosterone: testicular and endocrine responses at 14 months of age.  |  Thompson, DL., et al. 1985. J Anim Sci. 61: 1498-504. PMID: 3936832
8. Anabolic steroids: a review of the literature.  |  Haupt, HA. and Rovere, GD. 1984. Am J Sports Med. 12: 469-84. PMID: 6391216
9. Characterisation of monoclonal antibodies raised against testosterone.  |  Fantl, VE. and Wang, DY. 1983. J Steroid Biochem. 19: 1605-10. PMID: 6645496
10. Influence of antisera, purification procedures, and tracers on validity of a testosterone radioimmunoassay.  |  de Gomez, MS., et al. 1981. Ann Clin Biochem. 18: 281-6. PMID: 7305257
11. Effects of active immunization of female rabbits against testosterone.  |  Armstrong, RW., et al. 1978. J Endocrinol. 79: 339-47. PMID: 744928
12. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.  |  Roseman, BJ., et al. 1997. J Surg Oncol. 66: 215-20. PMID: 9369969

Monoclonal antibodies for mammalian and non-mammalian protein targets represent essentially all targets covered by polyclonal antibodies. Over 8,300 of our antibodies are offered as ImmunoCruz^® conjugates which eliminates the need for a secondary antibody.

Santa Cruz Biotechnology antibodies have over 360,000 research citations. Anti-Testosterone 3 CMO Antibody (3T16) has 0 citations in a variety of scientific publications.

Primary antibodies for mammalian target proteins are recommended for the detection of a range of mammalian species, primarily of mouse, rat and human species. Many mammalian antibodies are also ideal for veterinary research and reactive with ovine, porcine, caprine, feline, canine, bovine and equine protein targets. Santa Cruz Biotechnology primary monoclonal antibodies are suitable for laboratory research applications and are not intended for diagnostic or therapeutic use.

Testosterone 3 CMO Antibody (3T16) Specifications

Alternate Product Name: Testosterone 3 CMO

Product Clone Name: 3T16

Classification: Primary Antibody

Clonality: Monoclonal Antibody

Antibody Isotype: IgG₁ kappa light chain

Amino Acids:

Epitope Target: Testosterone 3 CMO

Epitope Species: N/A

Product Reactivity/Detection: Testosterone 3 CMO

Species Reactivity/Detection: N/A

Additional Mammalian Reactivity: N/A

Additional Non-Mammalian Reactivity: N/A

Applications: ELISA

Vialing Information: Each vial contains 200 µg IgG₁ kappa light chain in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin

Research Citations: 0 citations in various scientific publications

Available Conjugates/Forms for Testosterone 3 CMO Antibody (3T16): AC: Agarose, AF488: Alexa Fluor^® 488, AF546: Alexa Fluor^® 546, AF594: Alexa Fluor^® 594, AF647: Alexa Fluor^® 647, AF680: Alexa Fluor^® 680, AF790: Alexa Fluor^® 790, FITC: Fluoroscein, HRP: Horseradish Peroxidase, PE: Phycoerythrin